AGILE THERAPEUTICS INC Business Finance Contracts & Agreements
82 Contracts & Agreements
- Credit Agreements (16 contracts)
- Loan Agreements (4)
- Note Agreements (2)
- Purchase Agreements (6)
- Registration Rights Agreements (2)
- Security Agreements (1)
- Stock Agreements (7)
- Underwriting Agreements (6)
- Warrant Agreements (38)
- Intellectual Property Security Agreement dated June 25, 2024 by and between the Company and Exeltis USA, Inc (Filed With SEC on June 26, 2024)
- Revolving Promissory Note dated June 25, 2024, by and between the Company and Exeltis USA, Inc (Filed With SEC on June 26, 2024)
- Form of Placement Agent Warrant (Filed With SEC on February 23, 2024)
- Form of New Warrant (Filed With SEC on February 23, 2024)
- Form of New Warrant (Filed With SEC on February 23, 2024)
- Eighth Amendment to Credit Agreement and Guaranty, by and among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on February 15, 2024)
- Form of Securities Purchase Agreement, by and among Agile Therapeutics, Inc. and the purchasers signatory thereto (Filed With SEC on December 20, 2023)
- Form of Placement Agent Warrant (Filed With SEC on December 20, 2023)
- Form of Series F Pre-Funded Warrant (Filed With SEC on December 20, 2023)
- Form of Series E-2 Warrant (Filed With SEC on December 20, 2023)
- Form of Series E-1 Warrant (Filed With SEC on December 20, 2023)
- Seventh Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (Filed With SEC on December 11, 2023)
- Amendment to Warrants and Certificate of Adjustment between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of October 30, 2023 (Filed With SEC on December 11, 2023)
- Form of Warrant Amendment and Additional Issuance Agreement (Filed With SEC on December 4, 2023)
- Form of New Warrant (Filed With SEC on December 4, 2023)
- Form of Warrant Amendment Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain holders (Filed With SEC on May 25, 2023)
- Form of Securities Purchase Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain purchasers (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series B Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A-2 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A-1 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated April 25, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated October 8, 2021 (Filed With SEC on May 25, 2023)
- Form of Placement Agent warrant (Filed With SEC on May 25, 2023)
- Form of Series D Pre-funded warrant (Filed With SEC on May 25, 2023)
- Form of Series C-2 warrant (Filed With SEC on May 25, 2023)
- Form of Series C-1 warrant (Filed With SEC on May 25, 2023)
- Form of Securities Purchase Agreement, by and between Agile Therapeutics, Inc. and the purchasers signatory thereto (Filed With SEC on May 19, 2023)
- Form of Placement Agent Warrant (Filed With SEC on May 19, 2023)
- Form of Series D Pre-Funded Warrant (Filed With SEC on May 19, 2023)
- Form of Series C-2 Warrant (Filed With SEC on May 19, 2023)
- Form of Series C-1 Warrant (Filed With SEC on May 19, 2023)
- Waiver and Sixth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on April 14, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (Filed With SEC on March 23, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (Filed With SEC on March 23, 2023)
- Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (Filed With SEC on March 23, 2023)
- Fifth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (Filed With SEC on November 7, 2022)
- Form of Securities Purchase Agreement, dated July 1, 2022, by and between Agile Therapeutics, Inc. and certain purchasers (Filed With SEC on July 8, 2022)
- Form of Placement Agent warrant (Filed With SEC on July 8, 2022)
- Form of Series B Pre-funded warrant (Filed With SEC on July 8, 2022)
